BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37438803)

  • 1. Assessing the performance of European-derived cardiometabolic polygenic risk scores in South-Asians and their interplay with family history.
    Hassanin E; Maj C; Klinkhammer H; Krawitz P; May P; Bobbili DR
    BMC Med Genomics; 2023 Jul; 16(1):164. PubMed ID: 37438803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores for cardiometabolic traits demonstrate importance of ancestry for predictive precision medicine.
    Kember RL; Verma SS; Verma A; Xiao B; Lucas A; Kripke CM; Judy R; Chen J; Damrauer SM; Rader DJ; Ritchie MD
    Pac Symp Biocomput; 2024; 29():611-626. PubMed ID: 38160310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of polygenic risk scores to differentiate between type 1 and type 2 diabetes.
    Shoaib M; Ye Q; IglayReger H; Tan MH; Boehnke M; Burant CF; Soleimanpour SA; Gagliano Taliun SA
    Genet Epidemiol; 2023 Jun; 47(4):303-313. PubMed ID: 36821788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of optimal methods and ancestries for calculating polygenic risk scores in East Asian population.
    Kim DJ; Kang JH; Kim JW; Cheon MJ; Kim SB; Lee YK; Lee BC
    Sci Rep; 2023 Nov; 13(1):19195. PubMed ID: 37932343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the trans-ancestry polygenic risk score on type 2 diabetes risk, onset age and progression among population in Taiwan.
    Wang SH; Huang YC; Cheng CW; Chang YW; Liao WL
    Am J Physiol Endocrinol Metab; 2024 May; 326(5):E547-E554. PubMed ID: 38363735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.
    Truong B; Ruan Y; Haidermota S; Patel A; Surakka I; Hornsby W; Koyama S; Lee SH; Natarajan P
    Med; 2024 May; 5(5):459-468.e3. PubMed ID: 38642556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: A population-based cohort study.
    Hodgson S; Huang QQ; Sallah N; ; Griffiths CJ; Newman WG; Trembath RC; Wright J; Lumbers RT; Kuchenbaecker K; van Heel DA; Mathur R; Martin HC; Finer S
    PLoS Med; 2022 May; 19(5):e1003981. PubMed ID: 35587468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
    Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
    Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating European GWAS findings improve polygenic risk prediction accuracy of breast cancer among East Asians.
    Ji Y; Long J; Kweon SS; Kang D; Kubo M; Park B; Shu XO; Zheng W; Tao R; Li B
    Genet Epidemiol; 2021 Jul; 45(5):471-484. PubMed ID: 33739539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations.
    Ge T; Irvin MR; Patki A; Srinivasasainagendra V; Lin YF; Tiwari HK; Armstrong ND; Benoit B; Chen CY; Choi KW; Cimino JJ; Davis BH; Dikilitas O; Etheridge B; Feng YA; Gainer V; Huang H; Jarvik GP; Kachulis C; Kenny EE; Khan A; Kiryluk K; Kottyan L; Kullo IJ; Lange C; Lennon N; Leong A; Malolepsza E; Miles AD; Murphy S; Namjou B; Narayan R; O'Connor MJ; Pacheco JA; Perez E; Rasmussen-Torvik LJ; Rosenthal EA; Schaid D; Stamou M; Udler MS; Wei WQ; Weiss ST; Ng MCY; Smoller JW; Lebo MS; Meigs JB; Limdi NA; Karlson EW
    Genome Med; 2022 Jun; 14(1):70. PubMed ID: 35765100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European and US Guideline-Based Statin Eligibility, Genetically Predicted Coronary Artery Disease, and the Risk of Major Coronary Events.
    Park H; Kim D; You SC; Jang E; Yu HT; Kim TH; Kim DM; Sung JH; Pak HN; Lee MH; Yang PS; Joung B
    J Am Heart Assoc; 2024 May; 13(9):e032831. PubMed ID: 38639378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between polygenic risk of coronary artery disease and type 2 diabetes, lifestyle, and cardiovascular mortality: A prospective UK Biobank study.
    Yun JS; Jung SH; Shivakumar M; Xiao B; Khera AV; Park WY; Won HH; Kim D
    Front Cardiovasc Med; 2022; 9():919374. PubMed ID: 36061534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Lipoprotein(a) to Polygenic Risk Prediction of Coronary Artery Disease: A Prospective UK Biobank Analysis.
    Manikpurage HD; Paulin A; Girard A; Eslami A; Mathieu P; Thériault S; Arsenault BJ
    Circ Genom Precis Med; 2023 Oct; 16(5):470-477. PubMed ID: 37753708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-tuning of Genome-Wide Polygenic Risk Scores and Prediction of Gestational Diabetes in South Asian Women.
    Lamri A; Mao S; Desai D; Gupta M; Paré G; Anand SS
    Sci Rep; 2020 Jun; 10(1):8941. PubMed ID: 32488059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations.
    Ghatan S; van Rooij J; van Hoek M; Boer CG; Felix JF; Kavousi M; Jaddoe VW; Sijbrands EJG; Medina-Gomez C; Rivadeneira F; Oei L
    Genome Med; 2024 Jan; 16(1):10. PubMed ID: 38200577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations.
    Stalbow LA; Preuss MH; Smit RAJ; Chami N; Bjørkhaug L; Aukrust I; Gloyn AL; Loos RJF
    Diabetologia; 2023 Jan; 66(1):116-126. PubMed ID: 36216889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic comparison of family history and polygenic risk across 24 common diseases.
    Mars N; Lindbohm JV; Della Briotta Parolo P; Widén E; Kaprio J; Palotie A; ; Ripatti S
    Am J Hum Genet; 2022 Dec; 109(12):2152-2162. PubMed ID: 36347255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians.
    Wang M; Menon R; Mishra S; Patel AP; Chaffin M; Tanneeru D; Deshmukh M; Mathew O; Apte S; Devanboo CS; Sundaram S; Lakshmipathy P; Murugan S; Sharma KK; Rajendran K; Santhosh S; Thachathodiyl R; Ahamed H; Balegadde AV; Alexander T; Swaminathan K; Gupta R; Mullasari AS; Sigamani A; Kanchi M; Peterson AS; Butterworth AS; Danesh J; Di Angelantonio E; Naheed A; Inouye M; Chowdhury R; Vedam RL; Kathiresan S; Gupta R; Khera AV
    J Am Coll Cardiol; 2020 Aug; 76(6):703-714. PubMed ID: 32762905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-ancestry polygenic models for the prediction of LDL blood levels: an analysis of the United Kingdom Biobank and Taiwan Biobank.
    Hassanin E; Lee KH; Hsieh TC; Aldisi R; Lee YL; Bobbili D; Krawitz P; May P; Chen CY; Maj C
    Front Genet; 2023; 14():1286561. PubMed ID: 38075701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying factors that affect polygenic risk score performance across diverse ancestries and age groups for body mass index.
    Hui D; Xiao B; Dikilitas O; Freimuth RR; Irvin MR; Jarvik GP; Kottyan L; Kullo I; Limdi NA; Liu C; Luo Y; Namjou B; Puckelwartz MJ; Schaid D; Tiwari H; Wei WQ; Verma S; Kim D; Ritchie MD
    Pac Symp Biocomput; 2023; 28():437-448. PubMed ID: 36540998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.